The National Coalition on Health Care expresses significant disappointment that Congress did not act in 2019 to protect Americans from surprise medical bills or from high prescription drug prices.
Although we applaud the inclusion of CREATES Act in the final year-end spending package, which will help provide a boost to the generic drugs market, the end of the year package lacks any significant changes to drug policy that would protect Americans from the most expensive drugs. Americans have consistently indicated that high and increasing drug prices are the top concern, across both Democrats and Republicans.
In addition, Congress failed to act on “surprise” medical bills, despite bipartisan support to protect patient and a readily available compromise for providers and plans. Patients deserve better than for Congress to bend to private equity and providers who wish to exploit the complexity of our health care system for their benefit.
We urge Congress to act swiftly and with a sense of urgency in 2020 to protect patients from harmful drug prices and surprise bills.